Xcout Intel
IsomAb competitors & alternatives
The 12 closest competitors and alternatives to IsomAb among biotechnology companies — ranked by similarity to what IsomAb actually does, not by market-cap band.
Subscribe to see IsomAb’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About IsomAb
IsomAb is a biotechnology research company headquartered in Nottingham, United Kingdom, focused on developing isoform-specific humanized antibodies to treat cardiovascular and other serious diseases.
IsomAb at a glance
IsomAb is a biotechnology company headquartered in United Kingdom, founded in 2022. Its most recent funding round, Seed, raised $9.5M in February 2024.
IsomAb funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $9.5M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 IsomAb competitors
Ranked by semantic similarity — how close each company is to IsomAb by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Alchemab Therapeutics Ltd is a biotechnology company headquartered in London, England, focused on pioneering patient-centric antibody discovery and development.
Similar biotechnology company
Adimab is a biotechnology research company headquartered in Lebanon, New Hampshire, that serves as a biopharmaceutical industry partner for therapeutic antibody discovery and engineering.
Similar biotechnology company
ProtAb Ltd is an Israeli biotechnology company headquartered in Jerusalem that develops therapeutic agents and antibodies to modulate cytokine regulation for the treatment of autoimmune and inflammatory diseases.
Biotech
Numab Therapeutics is a Swiss biotechnology company developing multispecific antibody-based medicines that modulate immune-cell interactions. Its programs target serious diseases including cancer and immune-mediated or inflammatory disorders, serving patients through development and potential partnerships with pharmaceutical companies.
Life Sciences
KisoJi Biotechnology Inc. is a drug discovery company headquartered in Montreal, Canada, utilizing a proprietary antibody discovery platform to create next-generation antibody drugs.
Similar biotechnology company
DJS Antibodies is an Oxford-based biotechnology research company operating on the cutting edge of drug discovery and development, and is now a part of AbbVie.
Similar biotechnology company
ImaginAb, Inc. is a global biotechnology company headquartered in California, with operations in Los Angeles and San Diego. It focuses on developing next-generation imaging and radiopharmaceutical products for cancer immunology.
Similar biotechnology company
Imbria Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel cardiovascular therapies.
Similar biotechnology company
HeartBeat.bio is a biotechnology company founded in 2021 and located at the Vienna BioCenter in Austria, specializing in cardiac drug discovery. The company transforms cardiac drug recovery and development using innovative technologies originating from the Institute of Molecular Biotechnology (IMBA).
Similar biotechnology company
Vaderis Therapeutics AG is a clinical-stage biotechnology company focused on developing novel treatments for severe vascular diseases. The company is headquartered in Basel, Switzerland.
Similar biotechnology company
PhaseBio Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Malvern, Pennsylvania, with additional operations in San Diego, California. The company focuses on the discovery and development of novel biopharmaceuticals for cardiovascular and other severe diseases.
Biotech
Maxion Therapeutics is a biotechnology company headquartered in Cambridge, England, utilizing proprietary KnotBody technology to discover and develop first-in-class protein therapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of IsomAb and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for IsomAband every competitor above — in one live dashboard.
Subscribe to Xcout Intel →